title: Genomic HLA-DRB1 matching further improves clinical course after renal transplantation.
authors.affiliation: Surgical Department B, National Hospital, Oslo, Norway.
authors.forename: T
authors.initials: T
authors.lastname: Leivestad
authors.forename: A
authors.initials: A
authors.lastname: Spurkland
authors.forename: I
authors.initials: I
authors.lastname: Knutsen
authors.forename: A
authors.initials: A
authors.lastname: Bratlie
authors.forename: F
authors.initials: F
authors.lastname: Vartdal
authors.forename: P
authors.initials: P
authors.lastname: Pfeffer
authors.forename: G
authors.initials: G
authors.lastname: Sødal
authors.forename: P
authors.initials: P
authors.lastname: Fauchald
authors.forename: E
authors.initials: E
authors.lastname: Thorsby
mesh_terms: D000206:Actuarial Analysis; D000704:Analysis of Variance; D005802:Genes, MHC Class II; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival; D006684:HLA-DR Antigens / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D011379:Prognosis; D012044:Regression Analysis; D012189:Retrospective Studies; D015996:Survival Rate
chemical_list: D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains